ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 791,79
0,64%
Dow Jones
42 313,00
0,33%
DAX
19 473,63
1,32%
Brent Oil
72,01
0,00%
Bitcoin
65 688,60
-0,15%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TenX Keane Acquisition (TENK)

  7. TenX Keane Acquisition (TENK) Actualités

TENK

TenX Keane Acquisition (TENK)

TenX Keane Acquisition
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TENK
DateHeureSourceTitreSymboleSociété
09/08/202413h30GlobeNewswire Inc.TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market UpdateNASDAQ:TENKTenX Keane Acquisition
05/08/202414h00PR Newswire (US)Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.NASDAQ:TENKTenX Keane Acquisition
05/08/202414h00GlobeNewswire Inc.TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius PharmaceuticalsNASDAQ:TENKTenX Keane Acquisition
10/07/202415h10PR Newswire (US)Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage CandidatesNASDAQ:TENKTenX Keane Acquisition
10/01/202420h29GlobeNewswire Inc.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalNASDAQ:TENKTenX Keane Acquisition
24/10/202313h30GlobeNewswire Inc.Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKTenX Keane Acquisition
18/10/202322h00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKTenX Keane Acquisition
15/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TENKTenX Keane Acquisition
31/03/202322h33Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TENKTenX Keane Acquisition
14/02/202321h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKTenX Keane Acquisition
10/02/202322h40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TENKTenX Keane Acquisition
06/12/202222h58GlobeNewswire Inc.TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022NASDAQ:TENKTenX Keane Acquisition
18/10/202220h20GlobeNewswire Inc.TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment OptionNASDAQ:TENKTenX Keane Acquisition
14/10/202200h00GlobeNewswire Inc.TenX Keane Acquisition Announces Pricing of $60 Million Initial Public OfferingNASDAQ:TENKTenX Keane Acquisition
 Showing the most relevant articles for your search:NASDAQ:TENK

Dernières Valeurs Consultées

COIN
SOLUSD
Solana
EU
EN
Bouygues
COIN
AVAXUSD
Avalanche
EU
RNO
Renault
EU
BN
Danone
COIN
DOGEUSD
Dogecoin
EU
ORA
Orange
NASDAQ
AMZN
Amazon.com
EU
ACA
Credit Agricole
NYSE
JPM
JP Morgan Chase
EU
PX1
CAC 40
EU
AI
Air Liquide
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés